HOME QUICK SEARCH AUTHORS KEYWORDS HELP BUGS

intercurrent event

32 papers and 7 presentations; 39 titles.

Back to keywords

Conference × Year × Title × Authors Extras Pages
PharmaSUG CN 2026 A Standardized Programming Framework for Daily Dose Dataset Construction from Multi-Source Clinical Data Xianjun Li,
Chengye Lu
source 10
PharmaSUG CN 2026 ADICE: A Proposed ADaM Dataset Structure for Intercurrent Events in the Estimand Framework Lijie Zhu source 11
PharmaSUG CN 2026 Making Composite Endpoints Work: An ADaM Programming Approach to Sustained Remission Qing Xue,
Fen Wu,
Shuo Zhang,
Peixuan Wang
source 15
PharmaSUG CN 2026 Safety Estimands and Analysis Dataset Design: Advancing Safety Evaluation in Clinical Trials Kun Ren,
Zeyu Guang
source 11
PharmaSUG CN 2026 When Data Capture Becomes Data: How ePRO and e-Diary Systems Reshape CDISC Standards, Statistical Programming, and Endpoint Analysis in Vaccine Studies Jialiang Liu,
Lin Chen
source 16
PharmaSUG 2026 Beyond WHODrug: Insight into Concomitant Medication Data Analysis Song Liu,
Martin Nielsen,
Rambabu Sura
source 9
PharmaSUG 2026 Interactive Safety Data Visualization Platform: Transforming Adverse Event Analysis Review Through Dynamic Dashboards in Clinical Trials Nishanth Chinthala,
Alexandr Hromcenco
source 5
PHUSE US 2026 End-to-End Workflow for CDISC Estimand Framework in Clinical Trials Hiral Raval,
Simon Luo
source
poster source
12
PHUSE US 2026 Estimand-Aligned Multiple Imputation Strategies in CNS Trials with Complex Intercurrent Events Veera Thota,
Ian Lees
source
presentation source
6
PHUSE US 2026 Framework for Incorporating Estimands within the Statistical Analysis Plan Inderjeet Arora source
presentation source
9
PHUSE US 2026 From ATC to ACG: Implementing the Concomitant Medication Grouping (ACG) Dataset in Clinical Trial Analysis Michelle Starkell source
presentation source
8
PHUSE US 2026 Is Complexity Worth It? A Case Study Comparing Multiple Imputation Strategies Elnaz Ghadimi,
David Bushnell
source
poster source
4
PHUSE US 2026 Real-World Evidence Pavilion: Interactive Workshop: Bridging Estimands & Target Trial Emulation [presentation] Lauren Dang,
Matt Baldwin
source 7
PHUSE US 2026 Real-World Evidence Pavilion: Interactive Workshop: Bridging Estimands & Target Trial Emulation [presentation] Lauren Dang,
Matt Baldwin
source 6
PHUSE APAC 2026 Advancing Clinical Trial Analysis with Trimmed Means: Estimands, Intercurrent Events, and Regulatory Alignment Prasanth Palanisamy source
presentation source
9
PHUSE APAC 2026 Estimands Framework Through the Eye of a Statistical Programmer Shraddha Ganoo,
Kinjal Pandat
source
presentation source
9
PHUSE APAC 2026 Estimation of the Hypothetical Estimands using Longitudinal version of the TMLE Shreya Wahi source
presentation source
8
PHUSE APAC 2026 External Comparator Studies in the Era of Real-World Data Vishal Goriya,
Anshul Sinha,
Gerd Rippin
source
presentation source
5
PHUSE APAC 2026 Implementation of the ICH E9(R1) Estimands Framework Using Data Standards [presentation] Shahida Tamboli source 26
PHUSE APAC 2026 Internal Paper AS19 Time-to-Event Analysis in Pain Management: A Case Study of the Double Stopwatch Method and ADaM Dataset Development in Relation to Rescue Medication Arnode Mukherjee,
Abhishek Paul
source
presentation source
12
PHUSE APAC 2026 Invisible Influences: Estimands, Assumptions and Sensitivity in Inflammation & Immunologic Trial Interpretation Sukanya Erramachetty Subramanyam source
presentation source
8
PHUSE APAC 2026 Vision to Decision: An Ocular case study on Estimand Deepak Kumar source
presentation source
5
PHUSE EU 2025 Bridging the Gap: Translating Intercurrent Events into Analysis-Ready ADaM Datasets Meghna Diedrich source
poster source
9
PharmaSUG 2025 Guidance from the FDA authored "Submitting Patient-Reported Outcome Data in Cancer Clinical Trials" and recommendations for their implementation in study CDISC COA data. Charity Quick source 14
PharmaSUG 2025 Practical considerations for Intercurrent Events and Multiple Imputation David Bushnell source 6
PHUSE US 2025 Advancing Safety Evaluation in Oncology Trials Using Estimands Reshma Radhakrishnan,
Lakshmi Mantha
source
presentation source
8
PHUSE EU 2024 Estimands: How to Make ADaM Implementation Your Friend Jaclyn Amberg source
presentation source
10
PHUSE EU 2024 Strategies to Improve Understanding of Estimands and Analysis Section of Statistical Analysis Plan Inderjeet Arora source
presentation source
8
PHUSE EU 2024 Visual Monitoring of Intercurrent Events with Heatmap [poster] Alona Bulana source 1
PharmaSUG CN 2024 E9(R1) Program Practice and Its Application in Sensitivity Analysis Dawei Jiao source 6
PharmaSUG CN 2024 Implementing the treatment policy estimation for continuous variable with multiple imputation Andy Sun source 17
PharmaSUG CN 2024 Programming Perspective: Streamline Estimands, Strategies, and Design ADaM for Estimand Yuqin Wu source 10
PharmaSUG 2024 Dealing with Missing Data: Practical Implementation in SAS and R Isabella Y. Wang,
Lauren George,
Jin Xie
source 20
PharmaSUG 2024 Implementation of composite estimands for responder analysis based on change from baseline in non-solid tumours Reshma Radhakrishnan source 11
PharmaSUG 2024 Submitting Patient-Reported Outcome Data in Cancer Clinical Trials - Guidance for Industry Technical Specifications Document [presentation] Flora Mulkey source 48
PHUSE EU 2023 Implementation of Estimands Using Data Standards [presentation] Chris Price,
Alexandra Cochinaire
source 26
PHUSE US 2023 Implementation of Estimands (ICH E9 (R1)) Using Data Standards [presentation] Banoo Madhanagopal,
Lori Van Meter
source
video
32
PharmaSUG 2020 Principal Stratum strategy for handle intercurrent events: a causal estimand to avoid biased estimates Andrea Nizzardo,
Giovanni Marino Merlo,
Simona Scartoni
source 13
PHUSE EU 2018 Implementation of a Metadata-based Approach to Statistical Planning, Analysis and Reporting Frank Freischlager,
Hanspeter Schnitzer
source
presentation source
7

Back to keywords